Investor Day 2023
Watch Video
                       

"Iconic Solutions for Your Health and Wellness”

           Investor Day 2023
Watch Video
                       

"Iconic Solutions for Your Health and Wellness”

           Investor Day 2023
Watch Video
                       

"Iconic Solutions for Your Health and Wellness”

           Investor Day 2023
Watch Video
                       

"Iconic Solutions for Your Health and Wellness”

           Investor Day 2023
Watch Video
                       

"Iconic Solutions for Your Health and Wellness”

           Investor Day 2023
Watch Video
                       

"Iconic Solutions for Your Health and Wellness”

Earnings Releases

Quarterly 2023

4Q23 Earnings Conference Call


Fill the form to watch the video


    4Q23 Earnings Conference Call

    Quarterly 2022

    4Q22 Earnings Conference Call


    Fill the form to watch the video


      4Q22 Earnings Conference Call

      Sell-side Analyst Coverage

      Sell-side Analyst Coverage


      As of July 26, 2023 “LABB” is covered by 11 sell-side analysts at the following brokerages:


      FirmAnalystEmail
      Itaú BBAAlejandro Fuchsalejandro.fuchs@itaubba.com
      Banorte Carlos Hernandezcarlos.hernandez.garcia@banorte.com
      UBSRodrigo Alcántararodrigo.alcantara@ubs.com
      JP MorganJoseph Giordanojoseph.giordano@jpmorgan.com
      VectorMarco Antonio Montañez Torresmmontane@vector.com.mx
      ActinverValentin Mendozavmendoza@actinver.com.mx
      BBVA BancomerMiguel Ulloamiguel.ulloa@bbva.com
      MonexRoberto Solanojrsolano@monex.com.mx
      GBMLuis Willardlrwillard@gbm.com.mx
      BTG PactualAlvaro Garciaalvaro.garcia@btgpactual.com

      Itaú BBA

      Alejandro Fuchs

      alejandro.fuchs@itaubba.com

      Banorte 

      Carlos Hernandez

      carlos.hernandez.garcia@banorte.com

      UBS

      Rodrigo Alcántara

      rodrigo.alcantara@ubs.com

      JP Morgan

      Joseph Giordano

      joseph.giordano@jpmorgan.com

      Vector

      Marco Antonio Montañez Torres

      mmontane@vector.com.mx

      Actinver

      Valentin Mendoza

      vmendoza@actinver.com.mx

      BBVA Bancomer

      Miguel Ulloa

      miguel.ulloa@bbva.com

      Monex

      Roberto Solano

      jrsolano@monex.com.mx

      GBM

      Luis Willard

      lrwillard@gbm.com.mx

      BTG Pactual

      Alvaro Garcia

      alvaro.garcia@btgpactual.com

      Due to the abrupt devaluation of the Argentine peso in late December, accounting rules required Genomma Lab to record a non-cash negative impact on 4Q23 and full year 2023 earnings. However, excluding this extraordinary accounting effect, the Company’s core business is solid with good prospects. This information has been proactively and transparently presented, enabling investors to understand that this is an isolated event, not indicative of operating issues. Genomma remains committed to delivering value for its shareholders through a strong and growing business.

      Marco Sparvieri

      Chief Executive Officer

      February 22, 2024

      Our brands